Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
Asset disposition
Credit agrmnt [a]
Appointed director
Auditor change
Inv. presentation
|
|
Teligent, Inc. (TLGT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2020 |
8-K
| Quarterly results |
| 12/17/2014 |
8-K
| Asset disposition|
Docs:
|
"Indenture, by and between IGI Laboratories, Inc. and Wilmington Trust, National Association, as trustee",
"Purchase Agreement, by and among IGI Laboratories, Inc., Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC",
"IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 Buena, NJ - IGI Laboratories, Inc. announced today the closing of its offering of $125 million aggregate principal amount of 3.75% Convertible Senior Notes due 2019 . The Notes were offered and sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended . The Notes bear interest at a fixed rate of 3.75% per year, payable semiannually in arrears on June 15 and December 15 of each year, beginning on June 15, 2015 and mature on December 15, 2019, unless earlier repurchased, redeemed or converted. The Notes are convertible into shares of IGI’ s common stock, cash or a combination thereof. However, if IGI has not received stockholder approvals to incre..." |
|
|
|